Last reviewed · How we verify
NCT07249970: ADDICT AQUI
Understanding the Long-term Paths of People With Addictions
trial testing Addiction Severity Index in Addiction Disorders in 10,000 participants. Currently enrolling.
31 December 2030
Quick facts
| Lead sponsor | Centre Hospitalier Charles Perrens, Bordeaux |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 10,000 |
| Start date | 12 March 2002 |
| Primary completion | 31 December 2030 |
| Estimated completion | 31 December 2035 |
| Sites | 1 location across France |
Drugs / interventions tested
- Addiction Severity Index
Conditions studied
- Addiction Disorders — all drugs for Addiction Disorders →
- Addictive Behaviors — all drugs for Addictive Behaviors →
- Addiction — all drugs for Addiction →
Sponsor
Centre Hospitalier Charles Perrens, Bordeaux
Who can join
18 and older, any sex, with Addiction Disorders or Addictive Behaviors. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study is an open prospective cohort study. Participants are assessed at the start of their care in an addiction treatment unit using the Addiction Severity Index (ASI) and the Mini International Neuropsychiatric Interview (MINI), which are routinely conducted in these centers for individuals with substance use or behavioral disorders. After the study protocol is explained, the evaluator checks eligibility criteria, interested participants provide their written informed consent. The evaluator invites participants to complete self-administered questionnaires at home, which are returned during a session that also includes cognitive testing. Follow-up interviews are scheduled at 3 months, 6 months, and every 6 months thereafter.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07249970
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Centre Hospitalier Charles Perrens, Bordeaux trials
Trials by the same sponsor.
- NCT07309159 — Impact of Cannabis Consumption on Psychotic Symptoms and Reality Monitoring in Patients With Schizophrenia: a Real-life · Phase 1, PHASE2 · not yet recruiting
- NCT07008183 — Perinatal Thymic DYsregulation: Characterization of Perinatal Mood Episodes · NA · recruiting
- NCT06738784 — Evaluation of the Efficiency of the PRPP (Perceive, Recall, Plan and Perform) Task Analysis System on Support and Orient · NA · recruiting
- NCT05381883 — Mental Health of Professionals of the Silver Economy of New Aquitaine : Online Survey of Accommodation Establishments fo · NA · not yet recruiting
- NCT06476873 — Substance Use Disorder in Chemsex Practice · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07249970 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Charles Perrens, Bordeaux
- Last refreshed: 25 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07249970.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing